PORT WASHINGTON, N.Y., September 13, 2011 - Pall Corporation (NYSE:PLL) today introduced the new compact, easy-to-use Sentino Microbiology Pump for microbial analysis of aqueous samples using the Membrane Filter (MF) Technique. The Sentino Pump simplifies filtration while improving contamination control in pharmaceutical, beverage, and environmental water quality monitoring applications.
The Sentino Pump streamlines analysis by replacing the traditional vacuum filtration system with a small peristaltic-action pump that draws aqueous samples through a membrane filter. Filtrate is channeled directly to drain or waste collection. The unit’s compact design makes it easy to use in confined spaces and frees valuable benchtop space. It also provides flexibility in arranging workspace for optimal efficiency and workflow.
A soft-touch keypad featuring simple on/off and pulse functions makes it easy to operate, with no complicated programming to validate. Operating parameters are preset and fixed to meet the published requirements for MF Technique as described in US EPA, ISO, and ASTM methods, thereby eliminating the need for extensive validations.
The Sentino Pump simplifies maintenance and contamination control in two ways: peristaltic action and disposable Fluid Path. The peristaltic design ensures that fluid flows in one direction without the possibility of back-up, minimizing the potential for contamination of the sample. The disposable Fluid Path is easy to load and can be replaced before biofilm build-up becomes a contamination hazard and causes a false positive.
“Pall’s new Sentino Microbiology Pump is designed to improve the overall efficiency of microbiology laboratories utilizing the Membrane Filtration Technique. It reduces preparation time, simplifies testing, minimizes equipment maintenance, frees up lab space, and provides a level of contamination control often overlooked within the lab,” said Larry O’Connell, Senior Vice President, Pall Global Lab Products.
To learn more about other Pall Life Sciences products, visit www.pall.com.
About Pall Life Sciences
Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. Pall technologies are also used to collect and process blood components and help protect patients from hospital-acquired infections. The company’s membranes and membrane devices optimize detection and sample preparation in the drug research, clinical diagnostics, genomics, and proteomics markets. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce.
About Pall Corporation
Pall Corporation (NSYE:PLL) is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company's engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation, with total revenues of $2.4 billion for fiscal 2010, is an S&P 500 company with more than 10,000 employees serving customers worldwide. To see how Pall is helping enable a greener, safer, more sustainable future, follow us on Twitter @PallCorporation or visit www.pall.com/green.